Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of General Virology
|
July 24, 2014
Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents
Mahsa Shahidi, Enoch S E Tay, Scott A Read, et al.
The Journal of Biological Chemistry
|
July 15, 2003
hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer
Patsie Polly, Leila M Haddadi, Laura L Issa, et al.
The Biochemical Journal
|
June 5, 2003
Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity
Enoch S E Tay, Kim L Guven, Nanthakumar Subramaniam, et al.
International Journal of Molecular Sciences
|
May 27, 2023
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication
Mosleh Abomughaid, Enoch S E Tay, Russell Pickford, et al.
The Journal of Infectious Diseases
|
April 24, 2024
Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis
Sakthi Priya Selvamani, Anis Khan, Enoch S E Tay, et al.
The Journal of General Virology
|
May 26, 2016
Calsyntenin-1 mediates hepatitis C virus replication
Zunaira Awan, Enoch S E Tay, Nicholas S Eyre, et al.
The Journal of Biological Chemistry
|
December 17, 2009
Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism
Stephen J Palmer, Nicole Santucci, Jocelyn Widagdo, et al.
Gene Expression Patterns : GEP
|
January 24, 2007
Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development
Stephen J Palmer, Enoch S E Tay, Nicole Santucci, et al.
Hepatology Communications
|
June 4, 2020
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
Mark W Douglas, Enoch S E Tay, Dao Sen Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of General Virology
|
July 24, 2014
Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents
Mahsa Shahidi, Enoch S E Tay, Scott A Read, et al.
The Journal of Biological Chemistry
|
July 15, 2003
hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer
Patsie Polly, Leila M Haddadi, Laura L Issa, et al.
The Biochemical Journal
|
June 5, 2003
Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity
Enoch S E Tay, Kim L Guven, Nanthakumar Subramaniam, et al.
International Journal of Molecular Sciences
|
May 27, 2023
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication
Mosleh Abomughaid, Enoch S E Tay, Russell Pickford, et al.
The Journal of Infectious Diseases
|
April 24, 2024
Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis
Sakthi Priya Selvamani, Anis Khan, Enoch S E Tay, et al.
The Journal of General Virology
|
May 26, 2016
Calsyntenin-1 mediates hepatitis C virus replication
Zunaira Awan, Enoch S E Tay, Nicholas S Eyre, et al.
The Journal of Biological Chemistry
|
December 17, 2009
Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism
Stephen J Palmer, Nicole Santucci, Jocelyn Widagdo, et al.
Gene Expression Patterns : GEP
|
January 24, 2007
Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development
Stephen J Palmer, Enoch S E Tay, Nicole Santucci, et al.
Hepatology Communications
|
June 4, 2020
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
Mark W Douglas, Enoch S E Tay, Dao Sen Wang, et al.
Page
of 1